C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2001
11/15/2001	CA2408236A1 Peptide deformylase inhibitors
11/15/2001	CA2408095A1 Fluorous tagging compounds and their use
11/15/2001	CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/15/2001	CA2406512A1 Pharmaceutical compounds for treating copd
11/14/2001	EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001	EP1153919A1 Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active beta3 agonist by the use of the same
11/14/2001	EP1153014A2 Beta-alanine derivatives
11/14/2001	EP1152760A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
11/14/2001	EP1125928A9 Transition metal compounds, catalysts for the production of alpha-olefins and process therefor
11/14/2001	EP0923508B1 Process for preparing fluorine-containing compounds
11/14/2001	EP0762883B1 Pyridylbisphosphonates for use as a therapeutical agent
11/14/2001	EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001	CN1322197A New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/13/2001	US6316632 Process for preparing 2-phenyl-3-aminopyridine, substituted phenyl derivatives, thereof, and salts thereof
11/13/2001	US6316631 Process for converting 2,4-dichloropyridines into 2-aryloxy-4-chloropyridines
11/13/2001	US6316627 Process for the preparation of flecainide
11/13/2001	US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316484 Pentafluorobenzenesulfonamides and analogs
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316464 P38 MAP kinase inhibitors
11/13/2001	US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001	US6316450 Compounds
11/13/2001	US6316389 Dihydrobenzene pesticides
11/13/2001	US6316388 Antigrowth agents for plants
11/13/2001	US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same
11/08/2001	WO2001083459A2 Uracil substituted phenyl sulfamoyl carboxamides
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083434A2 P-(sulfonyl)-aryl and heteroaryls amines
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001083421A1 Process for the preparation of 2-halobenzoic acids
11/08/2001	WO2001060349A3 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof.
11/08/2001	WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/08/2001	WO2000017133A3 Lta4 hydrolase inhibitors
11/08/2001	US20010039344 Antidiabetic agents
11/08/2001	US20010039343 Pesticides, fungicides, herbicides, insecticides, microbiocdes, drugs
11/08/2001	US20010039279 Diamide compounds and compositions containing the same
11/08/2001	US20010039276 Phenethyl-thiourea compounds and use
11/08/2001	US20010039271 For treatment of male erectile dysfunction, female sexual dysfunction
11/08/2001	EP1144348A3 Lta 4? hydrolase inhibitors
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407189A1 New gamma selective retinoids
11/08/2001	CA2405832A1 P-(sulfonyl)aryl and heteroaryls
11/07/2001	EP1151998A1 Estrogen agonists/antagonists
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150956A1 Non-nucleoside reverse transcriptase inhibitors
11/07/2001	EP1150955A2 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
11/07/2001	EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP1150937A1 Liquid crystalline trifluoro-substituted compounds
11/07/2001	EP1150676A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
11/07/2001	EP0968189B1 Process for the preparation of nicotinic acids
11/07/2001	EP0946474B1 1,3-difluoronapthalene derivatives for liquid crystal mixtures
11/07/2001	EP0900082B1 Use of pyridyl- and pyrimidyl-piperazines for the manufacture of a medicament for the treatment of substance abuse disorders
11/07/2001	EP0879223B1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1321149A New crystal modification III of torasemide
11/07/2001	CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use
11/07/2001	CN1321087A MGluR 5 antagonists for treatment of pain and anxiety
11/07/2001	CN1320599A Limited 9-cis-isotretinoins
11/07/2001	CN1320597A Antifungal and its preparation method and intermediate
11/07/2001	CN1320596A Process for preparing substd. pyridines compounds
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	USRE37438 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
11/06/2001	US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants
11/06/2001	US6313245 Used in optical devices including optical waveguides and interconnecting devices
11/06/2001	US6313177 As antiviral agents
11/06/2001	US6313166 Used for pest control, as microbicides, insecticides and acaricides in agriculture, horticulture and in hygiene sector
11/06/2001	US6313162 Propynyl or dienyl biaromatic compounds
11/06/2001	US6313153 Administering pyridylacrylamide compound for therapy of nephritis
11/06/2001	US6313151 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313148 For therapy of pain pain associated with joint conditions such as rheumatoid arthritis and osteoarthritis, postoperative pain, post-partum pain, the pain associated with dental conditions such as dental caries and gingivitis
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/06/2001	US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001	US6313135 Analogues of camptothecin, preparation procedures, their application as medicines and the pharmaceutical compositions comprising them
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	US6313127 For therapy of hypercholesterolemia or atherosclerosis
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers
11/06/2001	US6312478 Two component kit; one component is a colorant comprising a monomethine or polymethine dye; second component consisting of a decolorizing agent
11/06/2001	CA2193178C Matrix metalloprotease inhibitors
11/06/2001	CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
11/01/2001	WO2001081355A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs
11/01/2001	WO2001081353A1 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081333A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
11/01/2001	WO2001081332A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
11/01/2001	WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081313A1 Pyridine compounds, arthropod controllers containing the same as the active ingredient and intermediates for the preparation of the compounds
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis

1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 633